All Stories

  1. Effect of a single prostaglandin F2α presynchrony 3 to 4 days prior to treatment of anestrous dairy cows with a novel intravaginal progesterone-releasing device and Ovsynch
  2. Effects of the addition of hydrocortisone aceponate to intramammary procaine penicillin for treatment of intramammary infections in dairy cattle
  3. Clinical and subclinical mastitis incidence in pasture-based dairy cows
  4. First identification of Bordetella bronchiseptica subclinical mastitis in a lactating dairy cow in New Zealand
  5. Epidemiology of antimicrobial resistance in commensal Escherichia coli from healthy dairy cattle on a Mediterranean pasture-based system of Australia: A cross-sectional study
  6. Mastitis in Cattle: Agents, Diagnosis, and Treatment
  7. Utility of an in-line somatic cell count sensor for selecting cows for dry-cow therapy
  8. Specificity of 2 peripartum blood markers for early-lactation acute uterine inflammation in pasture-fed, seasonal-calving dairy cows
  9. An Assessment of the Epidemiology and Herd-Level Impact of the Fractured Humerus Epidemic in New Zealand Dairy Cattle, 2007–2015: Results from Four Studies
  10. Invited review: Selective treatment of clinical mastitis in dairy cattle
  11. Invited review: Selective use of antimicrobials in dairy cattle at drying-off
  12. Bacteriological outcomes following random allocation to quarter-level selection based on California Mastitis Test score or cow-level allocation based on somatic cell count for dry cow therapy
  13. Therapy of Subclinical Mastitis during Lactation
  14. The epidemiology of AmpC-producing Escherichia coli isolated from dairy cattle faeces on pasture-fed farms
  15. Risk factors for clinical or subclinical mastitis following infusion of internal teat sealant alone at the end of lactation in cows with low somatic cell counts
  16. Detecting intramammary infection at the end of lactation in dairy cows
  17. Development of an intrauterine infection model in the postpartum dairy cow
  18. Antimicrobial susceptibilities in dairy herds that differ in dry cow therapy usage
  19. Cow-level risk factors for clinical mastitis in the dry period in cows treated with an internal teat sealant alone at the end of lactation
  20. Evaluation of fully oxidised β-carotene as a feed ingredient to reduce bacterial infection and somatic cell counts in pasture-fed cows with subclinical mastitis
  21. Increasing conception rate by addition of a second prostaglandin injection in an Ovsynch and progesterone treatment programme for dairy cows not detected in oestrus before the start of the seasonal mating period
  22. Effect of calf age on bovine viral diarrhea virus tests
  23. Evaluation of fully oxidized β-carotene as a feed ingredient to reduce bacterial infection and somatic cell counts in cows with subclinical mastitis
  24. Prevalence of endometritis diagnosed by vaginal discharge scoring or uterine cytology in dairy cows and herds
  25. Mechanisms of β-lactam resistance of Streptococcus uberis isolated from bovine mastitis cases
  26. Microtiter Screening Reveals Oxygen-Dependent Antimicrobial Activity of Natural Products Against Mastitis-Causing Bacteria
  27. Randomized, controlled, superiority study of extended duration of therapy with an intramammary antibiotic for treatment of clinical mastitis
  28. Risk factors for subclinical hypocalcaemia, and associations between subclinical hypocalcaemia and reproductive performance, in pasture-based dairy herds in New Zealand
  29. Effect of treatment with oral Ca boluses following calving on concentrations of Ca in serum in pasture-based dairy cows
  30. Pegbovigrastim treatment affects gene expression in neutrophils of pasture-fed, periparturient cows
  31. Predicting intramammary infection status at drying off using indirect testing of milk samples
  32. Proteomic content of circulating exosomes in dairy cows with or without uterine infection
  33. Identification of an immune modulation locus utilising a bovine mammary gland infection challenge model
  34. Addition of meloxicam to the treatment of bovine clinical mastitis results in a net economic benefit to the dairy farmer
  35. Effect of altering the type of dietary carbohydrate early postpartum on reproductive performance and milk production in pasture-grazed dairy cows
  36. Factors associated with colostrum quality in individual cows from dairy herds in the Waikato region of New Zealand
  37. Effect of exosomes from plasma of dairy cows with or without an infected uterus on prostaglandin production by endometrial cell lines
  38. Calf and replacement heifer mortality from birth until weaning in pasture-based dairy herds in New Zealand
  39. Effect of prepartum energy balance on neutrophil function following pegbovigrastim treatment in periparturient cows
  40. Associations between management practices and colostrum quality on New Zealand dairy farms
  41. Influence of preservation methods on the quality of colostrum sourced from New Zealand dairy farms
  42. Reproductive management of seasonally calving herds
  43. Invited review: A systematic literature review and meta-analysis of mortality and culling in dairy cattle
  44. Accuracy of fetal age estimates using transrectal ultrasonography for predicting calving dates in dairy cows in seasonally calving herds in New Zealand
  45. Concentrations of buparvaquone in milk and tissue of dairy cows
  46. Pathophysiology of humeral fractures in a sample of dairy heifers
  47. Addition of meloxicam to the treatment of clinical mastitis improves subsequent reproductive performance
  48. Body condition score and plane of nutrition prepartum affect adipose tissue transcriptome regulators of metabolism and inflammation in grazing dairy cows during the transition period
  49. Effect of infusing an internal teat sealant into a gland infected with a major pathogen
  50. Minimum inhibitory concentrations of selected antimicrobials against Escherichia coli and Trueperella pyogenes of bovine uterine origin
  51. Efficacy of controlled-release capsules containing monensin for the prevention of subclinical ketosis in pasture-fed dairy cows
  52. Subclinical ketosis in post-partum dairy cows fed a predominantly pasture-based diet: defining cut-points for diagnosis using concentrations of beta-hydroxybutyrate in blood and determining prevalence
  53. Associations between intrauterine bacterial infection, reproductive tract inflammation, and reproductive performance in pasture-based dairy cows
  54. Adipose and liver gene expression profiles in response to treatment with a nonsteroidal antiinflammatory drug after calving in grazing dairy cows
  55. Modulation of the immune system during postpartum uterine inflammation
  56. A randomised controlled study to assess the effects of an extension programme on the 6 week in-calf rate of seasonal calving, pasture-based dairy herds in New Zealand
  57. Effects of a group-based reproductive management extension programme on key management outcomes affecting reproductive performance
  58. Detection of bovine herpesvirus type 4 antibodies and bovine lymphotropic herpesvirus in New Zealand dairy cows
  59. Invited review: Systematic review of diagnostic tests for reproductive-tract infection and inflammation in dairy cows1
  60. Randomised controlled trials demonstrate efficacy of a novel internal teat sealant to prevent new intramammary infections in dairy cows and heifers
  61. Treatment with a nonsteroidal antiinflammatory drug after calving did not improve milk production, health, or reproduction parameters in pasture-grazed dairy cows
  62. Prevalence and incidence of intramammary infections in lactating dairy goats
  63. Use of herd management programmes to improve the reproductive performance of dairy cattle
  64. Postpartal Subclinical Endometritis Alters Transcriptome Profiles in Liver and Adipose Tissue of Dairy Cows
  65. Reproductive performance of seasonal-calving, pasture-based dairy herds in four regions of New Zealand
  66. Antimicrobial resistance inStaphylococcus aureus,Streptococcus uberisandStreptococcus dysgalactiaefrom dairy cows with mastitis
  67. Effect of prolonged duration therapy of subclinical mastitis in lactating dairy cows using penethamate hydriodide
  68. Use of an enzyme-linked immunosorbent assay for detecting bovine viral diarrhoea virus antibodies in individual cow milk samples
  69. Prevalence of subclinical ketosis in mainly pasture-grazed dairy cows in New Zealand in early lactation
  70. The responsiveness of subclinical endometritis to a nonsteroidal antiinflammatory drug in pasture-grazed dairy cows
  71. Clinical trial of treatment programs for purulent vaginal discharge in lactating dairy cattle in New Zealand
  72. Evaluation of three synchrony programs for pasture-based dairy heifers
  73. Invited review: Mastitis in dairy heifers: Nature of the disease, potential impact, prevention, and control
  74. Relationship between estimated breeding value for somatic cell count and prevalence of intramammary infection in dairy goats
  75. Molecular Epidemiology of Mastitis Pathogens of Dairy Cattle and Comparative Relevance to Humans
  76. Relationships between cytology, bacteriology and vaginal discharge scores and reproductive performance in dairy cattle
  77. Reproductive management of dairy herds in New Zealand: Attitudes, priorities and constraints perceived by farmers managing seasonal-calving, pasture-based herds in four regions
  78. Relationships between endometritis and metabolic state during the transition period in pasture-grazed dairy cows
  79. Diagnosis and treatment of subclinical mastitis in early lactation in dairy goats
  80. Effects of treatment of anestrous dairy cows with gonadotropin-releasing hormone, prostaglandin, and progesterone
  81. Effect of treatment with the nonsteroidal antiinflammatory meloxicam on milk production, somatic cell count, probability of re-treatment, and culling of dairy cows with mild clinical mastitis
  82. Association between gestational age and bovine fetal characteristics measured by transcutaneous ultrasound over the right flank of the dairy cow
  83. Comparison of transcutaneous ultrasound over the right flank with transrectal ultrasound for pregnancy diagnosis in the dairy cow
  84. Transcutaneous ultrasound over the right flank to diagnose mid‐ to late‐pregnancy in the dairy cow
  85. A review of prevention and control of heifer mastitis via non-antibiotic strategies
  86. Expression of innate resistance factors in mammary secretion from periparturient dairy heifers and their association with subsequent infection status
  87. Effect of application of an external teat sealant and/or oral treatment with a monensin capsule pre-calving on the prevalence and incidence of subclinical and clinical mastitis in dairy heifers
  88. Quarter-Level Analysis of Subclinical and Clinical Mastitis in Primiparous Heifers Following the Use of a Teat Sealant or an Injectable Antibiotic, or Both, Precalving
  89. Epidemiology of Mastitis in Pasture-Grazed Peripartum Dairy Heifers and Its Effects on Productivity
  90. Risk Factors for Peripartum Mastitis in Pasture-Grazed Dairy Heifers
  91. Association between endometritis diagnosis using a novel intravaginal device and reproductive performance in dairy cattle
  92. Mastitis in dairy production
  93. Subclinical and Clinical Mastitis in Heifers Following the Use of a Teat Sealant Precalving
  94. Reproduction Performance and Management of Dairy Cattle
  95. Factors affecting conception and expression of oestrus in anoestrous cows treated with progesterone and oestradiol benzoate
  96. Reproductive performance in anestrous dairy cows following treatment with two protocols and two doses of progesterone
  97. Effect of exogenous progesterone and oestradiol on plasma progesterone concentrations and follicle wave dynamics in anovulatory anoestrous post-partum dairy cattle
  98. The use of hormonal treatments to improve the reproductive performance of lactating dairy cows in feedlot or pasture-based management systems
  99. Resynchrony of postpartum dairy cows previously treated for anestrus
  100. Prevalence and incidence of subclinical mastitis in goats and dairy ewes in Vermont, USA
  101. Relationships among somatic cell count, California mastitis test, impedance and bacteriological status of milk in goats and sheep in early lactation
  102. GnRH induces ovulation of a dominant follicle in primiparous dairy cows undergoing anovulatory follicle turnover
  103. Patterns of follicular development during periods of anovulation in pasture-fed dairy cows after calving
  104. Some effects of feeding pasture silage as a supplement to pasture on reproductive performance in lactating dairy cows